N
Nan Lin
Researcher at Harvard University
Publications - 1220
Citations - 65601
Nan Lin is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 105, co-authored 687 publications receiving 54545 citations. Previous affiliations of Nan Lin include University of Michigan & Fujian Medical University.
Papers
More filters
Journal ArticleDOI
Physical Fitness and the Stress Process.
Walter M. Ensel,Nan Lin +1 more
TL;DR: The role of physical fitness in the life stress process for both psychological and physical well-being was examined in this paper, where the authors found that the more a person exercises, the less psychological or physical symptoms he or she will experience.
Journal ArticleDOI
Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
Weidong Lu,Anita Giobbie-Hurder,Rachel A. Freedman,Im Hee Shin,Nan Lin,Ann H. Partridge,David S. Rosenthal,Jennifer A. Ligibel +7 more
TL;DR: In a randomized controlled pilot trial of 40 breast cancer survivors with CIPN, an 8-week acupuncture intervention led to a statistically and clinically significant improvement in subjective sensory symptoms including neuropathic pain and paresthesia.
Journal ArticleDOI
Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology
Jeffrey Peppercorn,Iuliana Shapira,Deborah Collyar,Teresa L. Deshields,Nan Lin,Ian E. Krop,Hans Grunwald,Paula N. Friedman,Ann H. Partridge,Richard L. Schilsky,Monica M. Bertagnolli +10 more
TL;DR: Any cancer clinical trial that requires research biopsy of participants must be well designed to address the scientific question, obtain the biopsy in a way that minimizes risk, and ensure that research participants are fully informed of the risks, rationale, and requirements of the study, as well as of treatment alternatives.
Journal ArticleDOI
International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer.
Nan Lin,Christoph Thomssen,Fatima Cardoso,David Cameron,Tanja Cufer,Lesley Fallowfield,Prudence A. Francis,Stella Kyriakides,Olivia Pagani,Elżbieta Senkus,Alberto Costa,Eric P. Winer +11 more
TL;DR: Enhanced efforts to document quality of life over time should be made in order to more fully evaluate the risk/benefit ratio of available options.
Journal ArticleDOI
Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram.
Jonathan E. McDunn,Kareem D. Husain,Ashoka D. Polpitiya,Ashoka D. Polpitiya,Anton Burykin,Jianhua Ruan,Qing Li,William Schierding,Nan Lin,David Dixon,Weixiong Zhang,Craig M. Coopersmith,W. Michael Dunne,Marco Colonna,Bijoy K. Ghosh,Bijoy K. Ghosh,J. Perren Cobb +16 more
TL;DR: The data suggest that the onset of an infection-specific transcriptional program may precede the clinical diagnosis of pneumonia in patients, and riboleukograms may help explain variance in the host response due to differences in ethnic background, gender, and pathogen.